Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


FORM 8-K

 


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 28, 2006

 


Celsion Corporation

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware   000-14242   52-1256615

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

10220-L Old Columbia Road, Columbia, Maryland   21046-2364
(Address of principal executive office)   (Zip Code)

Registrant’s telephone number, including area code: (410) 290-5390

N/A

(Former name or former address, if changed since last report)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.135-4(c))

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 



Item 8.01 Other Events.

On May 3, 2006 Celsion Corporation (the “Company”) issued a press release disclosing that American Medical Systems, Inc. has filed a patent infringement lawsuit against it in the U.S. District Court for the District of Minnesota. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.  

Description

99.1   Press release issued by the Company May 3, 2006

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CELSION CORPORATION
Date: May 3, 2006   By:  

/s/ Anthony P. Deasey

   

Anthony P. Deasey

Executive Vice President, Chief Financial Officer and

Chief Operating Officer

 

S-1


Exhibit Index

 

Exhibit No.  

Description

99.1   Press release issued by the Company May 3, 2006

 

E-1